drugset / Trial / NCT01278433
A Safety Study of IMOVAX Polio Vaccine in Selected Cities in China
NaSingle-groupOpen-labelPrevention
Summary
The aim of the study is to collect post marketing safety data on IMOVAX Polio vaccine in China. Objective: To describe serious adverse events 30 days after each dose of IMOVAX Polio™ administered at 2, 3, and 4 months of age among infants living in the study cities of China.
Timeline
- Start
- 2010-12
- Primary completion
- 2011-12
- Completion
- 2012-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Inactivated Polio Vaccine | Vaccine | 0.5 ml | Intramuscular |